Perceptive Advisors LLC Pulmonx Corp Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $7.53 Million - $15 Million	-537,779 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $4.74 Million - $8 Million	-224,525 Reduced 29.45%	537,779 $13.3 Million
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $22.7 Million - $34.4 Million	762,304 New	762,304 $24.4 Million
Q1 2021 May 17, 2021	SELL	$44.0 - $67.54 $16.9 Million - $26 Million	-385,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $15.1 Million - $26.6 Million	385,000 New	385,000 $26.6 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.